Presentation, treatment, and outcome of type 1 gastric carcinoid tumors

Journal of Surgical Oncology

Volumn 93, Issue 5, 2006, Pages 368-372

  Dakin, Gregory F ^a   Warner, Richard R P ^b   Pomp, Alfons ^a   Salky, Barry ^b   Inabnet, William B ^c,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

ECL cell; Gastrectomy; Gastric carcinoid; Gastrin; Laparoscopic antrectomy

Indexed keywords

CHROMOGRANIN A; GASTRIN; OCTREOTIDE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CHROMOGRANIN; SOMATOSTATIN; TUMOR MARKER;

ABDOMINAL PAIN; ACIDIFICATION; ADULT; AGED; CANCER CLASSIFICATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTRECTOMY; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMAN; MALE; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STOMACH ANTRUM RESECTION; STOMACH CARCINOID; TREATMENT OUTCOME; ARTICLE; BLOOD; CARCINOID; DRUG ANTAGONISM; ENTEROCHROMAFFIN LIKE CELL; MIDDLE AGED; PATHOLOGY; STOMACH ANTRUM; STOMACH TUMOR;

ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOID TUMOR; CHROMOGRANIN A; CHROMOGRANINS; ENTEROCHROMAFFIN-LIKE CELLS; FEMALE; GASTRECTOMY; GASTRINS; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PYLORIC ANTRUM; RETROSPECTIVE STUDIES; SOMATOSTATIN; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33646184633     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20468     Document Type: Review

References (30)

1. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959.
2. Gilligan CJ, Lawton GP, Tang LH, et al.: Gastric carcinoid tumors: The biology and therapy of an enigmatic and controversial lesion. Am J Gastronenterol 1995;90:338-352.
3. Rindi G, Bordi C, Rappel S, et al.: Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. World J Surg 1996;20:168-172.
4. Granberg D, Wilander E, Stridsberg M, et al.: Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut 1998;43:223-228.
5. Rindi G, Luinetti O, Cornaggia M, et al.: Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study. Gastroenterology 1993;104:994-1006.
6. Schindl M, Kaserer K, Niederle B: Treatment of gastric neuroendocrine tumors: The necessity of a type-adapted treatment. Arch Surg 2001;136:49-54.
7. Modlin IM, Lye KD, Kidd M: Carcinoid tumors of the stomach. Surg Oncol 2003;12:153-172.
8. Yalow RS, Berson SA: Radioimmunoassay of gastrin. Gastroenterology 1970;58:1-14.
9. Ferraro G, Annibale B, Marignani M, et al.: Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. J Clin Endocrinol Metab 1996;81:677-683.
10. Wilander E, el-Salhy M, Pitkanen P: Histopathology of gastric carcinoids: A survey of 42 cases. Histopathology 1984;8:183-193.
11. DeSchryver-Kecskemeti K, Clouse R, Kraus F: Surgical pathology of gastric and duodenal neuroendocrine tumors masquerading as common polyps. Seminars Diagnostic Pathology 1984;1:5-12.
12. Sjoblom S: Clinical presentation and prognosis of gastrointestinal carcinoid tumors. Scand J Gastroenterol 1988;23:779-787.
13. Johansson H, Wilander E: A clinical study of 30 gastric carcinoids. Ups J Med Sci 1982;87:135-142.
14. Ho AC, Horton KM, Fishman EK: Gastric carcinoid tumors as a consequence of chronic hypergastrinemia: Spiral CT findings. Clin Imaging 2000;24:200-203.
15. Gough DB, Thompson GB, Crotty TB, et al: Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg 1994;18:473-479.
16. Ahlman H, Kolby L, Lundell L, et al.: Clinical management of gastric carcinoid tumors. Digestion 1994;55:77-85.
17. Modlin IM, Gilligan CJ, Lawton GP, et al.: Gastric carcinoids. The Yale Experience. Arch Surg 1995;130:250-255.
18. Borch K, Renvall H, Kullman E, et al.: Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases. Am J Surg Pathol 1987;11:435-444.
19. Thomas RM, Baybick JH, Elsayed AM, et al.: Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer 1994;73:2053-2058.
20. Hirschowitz BI, Griffith J, Pellegrin D, et al.: Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992;102:1409-1418.
21. Gonzalez Ramirez A, Lopez Roses L, Santos Blanco E, et al.: Multiple gastric carcinoid tumors: Endoscopic management. J Clin Gastroenterol 1996;23:75-77.
22. McAleese P, Moorehead J: Multiple gastric carcinoid tumours in a patient with pernicious anaemia: Endoscopic removal or gastric resection? Eur J Surg 1994;160:243-246.
23. Ichikawa J, Tanabe S, Koizumi W, et al.: Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 2003;35:203-206.
24. Kern SE, Yardley JH, Lazenby AJ, et al.: Reversal by antrectomy of endocrine cell hyperplasia in the gastric body in pernicious anemia: A morphometric study. Mod Pathol 1990;3:561-566.
25. Higham AD, Dimaline R, Varro A, et al.: Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology 1998;114:817-822.
26. Wangberg B, Grimelius L, Granerus G, et al.: The role of gastric resection in the management of multicentric argyrophil gastric carcinoids. Surgery 1990;108:851-857.
27. Moriyama T, Matsumoto T, Hizawa K, et al.: A case of multicentric gastric carcinoids without hypergastrinemia. Endoscopy 2003;35:86-88.
28. Otani Y, Ohgami M, Igarashi N, et al.: Laparoscopic wedge resection of gastric submucosal tumors. Surg Laparosc Endosc Percutan Tech 2000;10:19-23.
29. Otani Y, Furukawa T, Suganuma K, et al.: Minimally invasive surgery for gastric carcinoid tumor. Biomed Pharmacother 2002;56:217s-221s.
30. Jordan PH, Barroso A, Sweeney J. Gastric carcinoids in patients with hypergastrinemia. J Am Coll Surg 2005;199:552-555.